Short-term changes on MRI predict long-term changes on X-ray MRI is a valid method for monitoring joint damage in short-duration randomised clinical trials. INTRODUCTION Rheumatoid arthritis is a chronic inflammatory disease that affects a person’s joints, causing pain and disability. Although many treatments that stop inflammation and joint destruction have been introduced over the past […]
Month: June 2017
Moving young people with rheumatic diseases from paediatric to adult care
Introduction Recommendations give advice to doctors, other health professionals, patients and their families about the best way to treat and manage diseases. EULAR has written recommendations in partnership with Pediatric Rheumatology European Society (PReS) on the transitional care of young people with rheumatic diseases. Transitional care means moving young people from their childhood paediatric healthcare […]
Filgotinib is effective in people with insufficient response to methotrexate
Filgotinib improved signs and symptoms of rheumatoid arthritis over 24 weeks and was associated with fast onset of action. INTRODUCTION Rheumatoid arthritis is a chronic inflammatory disease that affects a person’s joints, causing pain and disability. Filgotinib belongs to a new group of medicines called targeted synthetic disease modifying antirheumatic drugs (sometimes also called tsDMARDs). […]
